Research article · 12 Jun 2025
Conference abstractPublished 2022
Nano-Formulation Can Potentially Increase Bioavailability Of Effective Drug In Brain
Jai Research Foundation, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The deadly virus HIV-1 causes HIV associated dementia (HAD). Although disease severity has been reduced by the successful introduction of combined antiretroviral therapy (cART), complete eradication of HIV-1 has not been possible yet, especially from the central nervous system (CNS). Neither it is possible to hit the HIV where it hides, nor to prevent the CNS infection and related CNS injury. In pre-HAART era HIV-associated dementia (HAD) was the most common (20-30%) worldwide among HIV infected AIDS people, especially subtype B predominant infections. Of the various subtypes of human immunodeficiency virus type I (HIV-1) and their recombinant forms, subtype C strains are responsible for approximately half of the global infections. In India, the low prevalence of HIV-associated dementia (HAD) in the Human immunodeficiency virus type 1 (HIV-1) subtype C infection is quite paradoxical given the high-rate of macrophage infiltration into the brain. Whether the direct viral burden in individual brain compartments could be associated with the variability of the neurologic manifestations is controversial. To understand this paradox, we examined the proviral DNA load in nine different brain regions and three different peripheral tissues derived from ten human subjects at autopsy. Blood Brain barrier has restricted permeable to highly active anti-retroviral drug (HAART). Specific brain-targeting drugs can be formulated using nanotechnology and those nano-formulation of these drugs, can potentially increase bioavailability of the effective drugs to specific targeted regions while preserving neurological integrity, which can give alternative therapeutic.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Pharmaceutics & Drug Delivery Research.
Research article · 20 Feb 2025
Sustained Drug Delivery in Pharmaceutical Dosage Forms for Novel Approaches of Formulation Design
Research article · 23 Jan 2025
Cutting Out Counterfeits: How Blockchain Can Revolutionize Drug Traceability?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutics & Drug Delivery Research
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Mamata Mishra”
